Neonatal Intensive Care Unit (NICU), Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha, P.O. Box 3050, Qatar.
Department of Medical Education, Hamad Medical Corporation (HMC), Doha, Qatar.
BMC Pregnancy Childbirth. 2021 Sep 24;21(1):651. doi: 10.1186/s12884-021-04124-6.
Diabetes Mellitus (DM) is a major cause of maternal, fetal, and neonatal morbidities. Our objective was to estimate the effect of both pre-pregnancy and gestational DM on the growth parameters of newborns in the Qatari population.
In this population-based cohort study, we compared the data of neonates born to Qatari women with both pre-pregnancy and gestational diabetes mellitus in 2017 with neonates of healthy non-diabetic Qatari women.
Out of a total of 17020 live births in 2017, 5195 newborns were born to Qatari women. Of these, 1260 were born to women with GDM, 152 were born to women with pre-pregnancy DM and 3783 neonates were born to healthy non-diabetic (control) women. The prevalence of GDM in the Qatari population in 2017 was 24.25%. HbA1C% before delivery was significantly higher in women with pre-pregnancy DM (mean 6.19 ± 1.15) compared to those with GDM (mean 5.28 ± 0.43) (P <0.0001). The mean birth weight in grams was 3066.01 ± 603.42 in the control group compared to 3156.73 ± 577.88 in infants born to women with GDM and 3048.78 ± 677.98 in infants born to women with pre-pregnancy DM (P <0.0001). There was no statistically significant difference regarding the mean length (P= 0.080), head circumference (P= 0.514), and rate of major congenital malformations (P= 0.211). Macrosomia (Birth weight > 4000 gm) was observed in 2.7% of the control group compared to 4.8% in infants born to women with GDM, and 4.6% in infants born to women with pre-pregnancy DM (P= 0.001). Multivariate logistic regression analysis demonstrated that higher maternal age (adjusted OR 2.21, 95% CI 1.93, 2.52, P<0.0001), obesity before pregnancy (adjusted OR 1.71, 95% CI 1.30, 2.23, P<0.0001), type of delivery C-section (adjusted OR 1.25, 95% CI 1.09, 1.44, P=0.002), and body weight to gestational age LGA (adjusted OR 2.30, 95% CI 1.64, 2.34, P<0.0001) were significantly associated with increased risk of GDM.
Despite the multi-disciplinary antenatal diabetic care management, there is still an increased birth weight and an increased prevalence of macrosomia among the infants of diabetic mothers. More efforts should be addressed to improve the known modifiable factors such as women's adherence to the diabetic control program. Furthermore, pre-pregnancy BMI was found to be significantly associated with gestational DM, and this is a factor that can be addressed during pre-conceptional counseling.
糖尿病(DM)是孕产妇、胎儿和新生儿发病率的主要原因。我们的目的是估计孕前和妊娠期糖尿病对卡塔尔人群新生儿生长参数的影响。
在这项基于人群的队列研究中,我们比较了 2017 年患有孕前和妊娠期糖尿病的卡塔尔妇女所生新生儿的数据与健康非糖尿病(对照)卡塔尔妇女所生新生儿的数据。
在 2017 年总共 17020 例活产中,有 5195 例新生儿为卡塔尔妇女所生。其中,1260 例为妊娠期糖尿病妇女所生,152 例为孕前糖尿病妇女所生,3783 例为健康非糖尿病(对照)妇女所生。2017 年卡塔尔人群妊娠期糖尿病的患病率为 24.25%。孕前糖尿病妇女的分娩前 HbA1C%明显高于妊娠期糖尿病妇女(均值 6.19 ± 1.15 比 5.28 ± 0.43)(P <0.0001)。对照组新生儿出生体重均值为 3066.01 ± 603.42 克,与妊娠期糖尿病妇女所生新生儿的 3156.73 ± 577.88 克和孕前糖尿病妇女所生新生儿的 3048.78 ± 677.98 克相比(P <0.0001)。新生儿的平均长度(P= 0.080)、头围(P= 0.514)和主要先天畸形发生率(P= 0.211)无统计学显著差异。对照组巨大儿(出生体重>4000 克)发生率为 2.7%,妊娠期糖尿病妇女所生新生儿为 4.8%,孕前糖尿病妇女所生新生儿为 4.6%(P= 0.001)。多变量逻辑回归分析显示,母亲年龄较大(调整比值比 2.21,95%置信区间 1.93,2.52,P<0.0001)、孕前肥胖(调整比值比 1.71,95%置信区间 1.30,2.23,P<0.0001)、剖宫产分娩(调整比值比 1.25,95%置信区间 1.09,1.44,P=0.002)和体重与胎龄 LGA(调整比值比 2.30,95%置信区间 1.64,2.34,P<0.0001)与妊娠期糖尿病的风险增加显著相关。
尽管进行了多学科的产前糖尿病护理管理,但糖尿病母亲的新生儿出生体重仍较高,巨大儿的发生率仍较高。应进一步努力改善已知的可改变因素,如妇女对糖尿病控制方案的依从性。此外,孕前 BMI 与妊娠期糖尿病显著相关,这是可以在孕前咨询中解决的因素。